Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net
Prepaid expenses and other current assets
Restricted cash, short-term
Total current assets
Property, equipment and software, net
Deferred offering costs
Restricted cash, long-term
Other long-term assets
Total assets
Liabilities and Stockholders’ equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Short-term debt
Revolving line of credit
Total current liabilities
Long-term debt, net
Other long-term liabilities
Total liabilities
Convertible preferred stock
Convertible Series A Preferred Stock
Convertible Series B Preferred Stock
Convertible Series C Preferred Stock
Convertible Series D Preferred Stock
Total convertible preferred stock
Stockholders’ equity:
Common stock, $0.00005 par value; 500,000,000 shares authorized, 6,632,889 and 6,764,021 shares issued and outstanding as of December 31, 2016 and June 30, 2017, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support